PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'APHP, Hôpital Saint Antoine, Service d\'Hématologie Clinique et de Thérapie cellulaire, Paris, France. florent.malard@inserm.fr.\', \'Sorbonne Université, INSERM UMR938, Centre de Recherche Saint-Antoine (CRSA), F-75012, Paris, France. florent.malard@inserm.fr.\', \'APHP, Hôpital Saint Antoine, Service d\'Hématologie Clinique et de Thérapie cellulaire, Paris, France.\', \'Sorbonne Université, INSERM UMR938, Centre de Recherche Saint-Antoine (CRSA), F-75012, Paris, France.\', \'APHP, Hôpital Saint Antoine, Department of Virology, Paris, France.\', \'Department of Medical Oncology, University Hospital of Besançon, INSERM, EFS BFC, UMR1098 RIGHT, Université de Bourgogne Franche-Comté, Besançon, France.\', \'Sorbonne Université Institut Pierre Louis d\'Epidémiologie et de Santé Publique, INSERM UMR S1136, Paris, France.\', \'APHP, Hôpital Saint Antoine, Service d\'Immunologie, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41408-021-00534-z
?:hasPublicationType
?:journal
  • Blood cancer journal
is ?:pmid of
?:pmid
?:pmid
  • 34376633
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.727
?:rankingScore_hIndex
  • 30
?:title
  • Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34376633>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34376633>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all